citric acid, anhydrous has been researched along with Venous Thrombosis in 4 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The notification of serious adverse events occurring resulting from the collection of blood or blood components is a statutory requirement." | 2.46 | [Serious adverse effects of blood collection]. ( Danic, B; Lefort, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schilder, L | 1 |
| Nurmohamed, SA | 1 |
| ter Wee, PM | 1 |
| Paauw, NJ | 1 |
| Girbes, AR | 1 |
| Beishuizen, A | 1 |
| Beelen, RH | 1 |
| Groeneveld, AB | 1 |
| Passero, BA | 1 |
| Zappone, P | 1 |
| Lee, HE | 1 |
| Novak, C | 1 |
| Maceira, EL | 1 |
| Naber, M | 1 |
| Baker, PM | 1 |
| Howgate, SJ | 1 |
| Atherton, J | 1 |
| Keeling, DM | 1 |
| Danic, B | 1 |
| Lefort, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition[NCT04756427] | Phase 4 | 1 participants (Actual) | Interventional | 2022-03-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for citric acid, anhydrous and Venous Thrombosis
| Article | Year |
|---|---|
[Serious adverse effects of blood collection].
Topics: Anticoagulants; Arteries; Blood Component Removal; Blood Donors; Citric Acid; Hematoma; Humans; Inci | 2010 |
1 trial available for citric acid, anhydrous and Venous Thrombosis
| Article | Year |
|---|---|
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients.
Topics: Adult; Aged; Anticoagulants; Citric Acid; Complement C5a; Critical Care; Critical Illness; Drug Syne | 2014 |
2 other studies available for citric acid, anhydrous and Venous Thrombosis
| Article | Year |
|---|---|
Citrate versus heparin for apheresis catheter locks: an efficacy analysis.
Topics: Anticoagulants; Blood Component Removal; Catheter-Related Infections; Catheterization, Central Venou | 2015 |
Comparison of a point of care device against current laboratory methodology using citrated and EDTA samples for the determination of D-dimers in the exclusion of proximal deep vein thrombosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Edetic Acid; Female; Fibrin Fibrinogen Degr | 2010 |